Twins born from 13-year-old frozen sperm
A protein known to inhibit the growth of ovarian cancer works in part by forcing cancer cells to eat themselves until they die, researchers at The University of Texas M. D. Anderson Cancer Center report in the Nov. 15 issue of Cancer Research. The research team also found that expression of the protein, known as
Full Post: PEA-15 protein points to potential targeted approach for ovarian cancer
Reports from Taiwan say the sperm taken from a man with testicular cancer 13 years ago has been successfully used to impregnate his wife.
The man was diagnosed with testicular cancer when he was 23, and sperm was taken and frozen before chemotherapy was used to treat the cancer as it was expected to render him infertile.
The 13-year-old frozen sperm of the former testicular cancer patient was used to artificially inseminate his wife who gave birth to healthy twin boys.
Chen, now age 36, has completely recovered from the cancer and is in good health and his wife became pregnant with two of the four banked embryos following a 37-week pregnancy.
Testicular cancer is an abnormal, rapid, and invasive cancer of the testicles and is one of the most common forms of cancer in young men 15 to 40 years old, accounting for 1% of all cancers in men.
Between 6,000 and 8,000 men are diagnosed with testicular cancers each year and treatment can involve surgery, radiotherapy and chemotherapy and in most cases fertility is compromised.
As testicular cancer strikes men at an age when most want to father children, nerve-sparing surgery and sperm banking is recommended by most doctors.
The use of chemotherapy following surgery reduces the risk of death from operable pancreatic cancer by around 30 per cent, says new research published in the British Journal of Cancer.Pancreatic cancer is the tenth most common cancer. Nearly 7,600 people are diagnosed with the disease in the UK each year. But, survival rates remain a
Full Post: Chemo boosts survival rates for pancreatic cancer
Contrary to common scientific belief, the length of a sperm’s tail does not always determine how fast it can swim. Research published in the open access journal BMC Evolutionary Biology has shown that in the counter-intuitive microscopic world in which sperm operate, streamlining and longer tails don’t always provide a speed advantage. Stuart Humphries, from
Full Post: Big sperm not necessarily fastest
Results of a phase III, international randomized clinical trial demonstrate a new standard of care for treating advanced ovarian cancer that significantly reduces side-effects and post-operative deaths compared to the previously established treatment course. The study, presented at the 12th Biennial Meeting of the International Gynecologic Cancer Society (IGCS) in Bangkok in October, has a
Full Post: New standard of care for treating advanced ovarian cancer
A small percentage of males born with cryptorchidism (failure of one or both testicles to descend into the scrotum), the most frequent congenital birth defect in male children, are more likely to have genetic mutations, including for a syndrome that is a common genetic cause of infertility, according to a study in the November 19
Full Post: Link found between cryptorchidism and genetic mutations
Power3 Medical Products, Inc. said today that two CIP patent applications have been filed for BC-SeraPro Breast Cancer blood test and biomarkers by Dr. Ira Goldknopf, its president and Chief Scientific Officer. The applications for utility patents are entitled “Identities, Specificities, and Use of Twenty Two (22) Differentially Expressed Protein Biomarkers for Blood Based Diagnosis
Full Post: Power3 Medical files two patent applications for breast cancer blood test